7416-34-4

7416-34-4 structure

Name: Molindone
Chemical Name: 3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one
CAS Number: 7416-34-4
Molecular Formula: C₁₆H₂₄N₂O₂
Molecular Weight: 276.37400
Catalog: API Nervous system medication Antidepressant, manic
Create Date: 2018-07-09 17:10:18
Modify Date: 2024-01-02 12:03:32
Molindone ((±)-Molindone), an indole derivative, is a potent dopamine D2 and D5 receptor antagonist. Molindone ((±)-Molindone) can be used for the research of schizophrenia and severe mental illness[1][2].

Name	3-Ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one
Synonyms	3-ethyl-2-methyl-5-morpholin-4-ylmethyl-1,5,6,7-tetrahydro-indol-4-one MOLINDONE molidone hydrochloride EN-1733A

Description	Molindone ((±)-Molindone), an indole derivative, is a potent dopamine D2 and D5 receptor antagonist. Molindone ((±)-Molindone) can be used for the research of schizophrenia and severe mental illness[1][2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease
References	[1]. Krishna G, et al. In vitro and in vivo genotoxicity assessment of the dopamine receptor antagonist molindone hydrochloride. Environ Mol Mutagen. 2016;57(4):288-298. [2]. Bagnall A, et al. Molindone for schizophrenia and severe mental illness. Cochrane Database Syst Rev. 2007;(1):CD002083. Published 2007 Jan 24.

Density	1.14 g/cm3
Boiling Point	462.9ºC at 760 mmHg
Melting Point	180 - 181ºC
Molecular Formula	C₁₆H₂₄N₂O₂
Molecular Weight	276.37400
Flash Point	233.7ºC
Exact Mass	276.18400
PSA	45.33000
LogP	1.90070
Index of Refraction	1.559
Water Solubility	H2O: 19 mg/mL

CHEMICAL IDENTIFICATION

RTECS NUMBER :: NM3300000

CHEMICAL NAME :: Indol-4(5H)-one, 3-ethyl-6,7-dihydro-2-methyl-5-(morpholinomethyl)-

CAS REGISTRY NUMBER :: 7416-34-4

LAST UPDATED :: 199801

DATA ITEMS CITED :: 2

MOLECULAR FORMULA :: C16-H24-N2-O2

MOLECULAR WEIGHT :: 276.42

WISWESSER LINE NOTATION :: T56 BM FV&TJ C1 D2 G1- AT6N DOTJ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Human

DOSE/DURATION :: 714 ug/kg/D

TOXIC EFFECTS :: Behavioral - somnolence (general depressed activity) Behavioral - tremor Behavioral - antipsychotic

REFERENCE :: 34ZIAG "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969 Volume(issue)/page/year: -,402,1969

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Human - man

DOSE/DURATION :: 4285 ug/kg/3D-I

TOXIC EFFECTS :: Behavioral - muscle weakness Lungs, Thorax, or Respiration - cyanosis Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis)

REFERENCE :: JCLPDE Journal of Clinical Psychiatry. (Physicians Postgraduate Press, Inc., POB 240008, Memphis, TN 38124) V.39- 1978- Volume(issue)/page/year: 47,607,1986

Hazard Codes	Xn: Harmful;
Risk Phrases	22
RIDADR	UN 2811 6.1/PG 3
WGK Germany	3
RTECS	NM3325000

5625-90-1

6116-76-3

~60%

7416-34-4

Literature: Hanbauer, Martin; Nazir, Zarghun; Hildebrand, Peter; Figini, Attilia; Liang, Likan; Fumagalli, Tiziano Patent: US2014/81020 A1, 2014 ; Location in patent: Paragraph 0137; 0138 ;

32818-79-4

7416-34-4

Literature: US2014/81020 A1, ;

504-02-9

7416-34-4

Literature: US2014/81020 A1, ;

600-14-6

7416-34-4

Literature: US2014/81020 A1, ;

Precursor 5
5625-90-1 6116-76-3 32818-79-4 504-02-9
600-14-6
DownStream 0

7416-34-4	1189805-13-7
15622-65-8	1158522-08-7
940364-43-2	134104-43-1
131615-57-1	2229106-72-1
6906-52-1	930439-75-1
1018584-77-4	2171539-63-0
2172222-48-7